Prostate Cancer Trials Underway Overseas PRO-RVLYSIN(R) CZ BioMed Corp.

TAMPA, FL-- - CZ BioMed Corp. announced today the successful collaboration with the Florida based Prostate Cancer Prevention Foundation , allowing overseas trials of CZ BioMed's new treatment for prostate ...

New Research Suggests Walnuts May Help Fight Prostate Cancer

FOLSOM, Calif., Jan. 25, 2012 /PRNewswire/ -- Prostate cancer is a major health concern for men that strikes approximately one in six men and is a leading cause of male cancer deaths in the United States(1).  ...

Prostate cancer study proves drug delays disease progression

( University Health Network ) For men diagnosed with low-risk, localized prostate cancer, being treated with the drug dutasteride (Avodart) delays disease progression and initiating active treatment, and also reduces anxiety, show the results of a three-year international clinical trial led by Dr. Neil Fleshner, Head of the Division of Urology, University Health Network.

Men and Women with Advanced Prostate or Breast Cancer and Bone Metastases in Quebec Now Have Access to New Medication

Quebec shows leadership in supporting men and women with advanced prostate and breast cancer OTTAWA , Feb. 1, 2012 /CNW/ - Today the Canadian Cancer Survivor Network (CCSN) congratulates the Quebec government ...

Arthritis and Cholesterol Drugs Well Tolerated in Prostate Cancer Treatment

Research from The Cancer Institute of New Jersey on the FDA-approved drugs Celebrex(r) and Lipitor(r) -- used respectively for arthritis pain and lowering cholesterol -- shows that these drugs are well tolerated in the treatment of recurrent prostate cancer. Preliminary results from an ongoing Phase II clinical trial will be presented this week during the 2012 Genitourinary Cancers Symposium.